ImmuCell Corp. (ICCC)
11.25
-0.08
(-0.71%)
USD |
NASDAQ |
Nov 18, 16:00
11.25
0.00 (0.00%)
After-Hours: 20:00
ImmuCell Price : 11.25 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 17, 2026 | 11.46 | 11.72 | 10.79 | 11.33 | 18535.00 |
| Nov 16, 2026 | 10.75 | 11.66 | 10.74 | 11.42 | 101747.0 |
| Nov 13, 2026 | 10.70 | 10.82 | 10.50 | 10.75 | 40753.00 |
| Nov 12, 2026 | 10.21 | 10.32 | 10.20 | 10.22 | 19304.00 |
| Nov 11, 2026 | 10.27 | 10.27 | 10.00 | 10.19 | 3368.00 |
| Nov 10, 2026 | 10.39 | 10.40 | 10.26 | 10.26 | 2873.00 |
| Nov 09, 2026 | 9.94 | 10.40 | 9.94 | 10.22 | 6265.00 |
| Nov 06, 2026 | 9.950 | 10.00 | 9.70 | 9.80 | 8243.00 |
| Nov 05, 2026 | 10.40 | 10.40 | 9.60 | 9.95 | 7337.00 |
| Nov 04, 2026 | 10.10 | 10.53 | 10.10 | 10.37 | 5695.00 |
| Nov 03, 2026 | 10.35 | 10.56 | 10.25 | 10.25 | 5984.00 |
| Nov 02, 2026 | 10.38 | 10.56 | 10.38 | 10.56 | 2033.00 |
| Oct 30, 2026 | 10.25 | 10.40 | 9.979 | 10.26 | 11021.00 |
| Oct 29, 2026 | 10.42 | 10.57 | 10.27 | 10.32 | 3319.00 |
| Oct 28, 2026 | 10.64 | 10.64 | 10.62 | 10.62 | 924.00 |
| Oct 27, 2026 | 10.50 | 10.50 | 10.25 | 10.26 | 4167.00 |
| Oct 26, 2026 | 10.23 | 10.36 | 10.21 | 10.24 | 2557.00 |
| Oct 23, 2026 | 10.36 | 10.37 | 10.19 | 10.25 | 11335.00 |
| Oct 22, 2026 | 10.44 | 10.44 | 10.26 | 10.44 | 5772.00 |
| Oct 21, 2026 | 10.50 | 10.61 | 10.40 | 10.52 | 7128.00 |
| Oct 20, 2026 | 10.50 | 10.50 | 10.42 | 10.45 | 4195.00 |
| Oct 19, 2026 | 10.67 | 10.67 | 10.50 | 10.51 | 6525.00 |
| Oct 16, 2026 | 10.78 | 10.78 | 10.57 | 10.75 | 2902.00 |
| Oct 15, 2026 | 10.45 | 10.88 | 10.45 | 10.56 | 9871.00 |
| Oct 14, 2026 | 10.80 | 10.80 | 10.50 | 10.75 | 9405.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 17.84 |
| Alnylam Pharmaceuticals, Inc. | 149.48 |
| Anika Therapeutics, Inc. | 13.62 |
| Savara, Inc. | 4.735 |
| Arrowhead Pharmaceuticals, Inc. | 43.12 |
Price Related Metrics
| PE Ratio | 55.80 |
| PS Ratio | 3.098 |
| Price to Book Value | 3.120 |
| Price to Free Cash Flow | 19.05 |
| Earnings Yield | 1.79% |
| Market Cap | 102.27M |
| Operating PE Ratio | 36.69 |
| Normalized PE Ratio | 43.98 |